Fermenta Biotech Ltd Share Price

AGM Date: 12 Aug 2022

AGM 12/08/2022 Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herewith enclose the electronic copy of the Annual Report of the Company for the financial year 2021-22 (along with the Notice of 70th AGM of the Company which is scheduled to be held on Friday, August 12, 2022 at 4:00 p.m. IST) which is sent to all the members whose email IDs were registered with the Company / Depository Participant(s). The requirement of sending physical copies of the above to the members has been dispensed with in accordance with relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The Annual Report of the Company for the financial year 2021-22 along with the Notice of 70th AGM is also uploaded on the website of the Company at https://fermentabiotech.com/annual-report.php (As Per BSE Announcement Dated on 16.07.2022) Pursuant to Regulation 44 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the results of remote e-voting (including ballot forms and electronic voting at the Annual General Meeting) on all the resolutions set out in the notice of the 70th Annual General Meeting of the Company held on August 12, 2022 through Video Conferencing/Other Audio Visual Means. Kindly take the same on record. Pursuant to the provisions of Regulation 30 of Listing Regulations, we hereby inform that the members of the Company at the 70th Annual General Meeting held today ('AGM'), have approved the following: (i) Appointment of Directors (ii) Appointment of new Statutory Auditors (iii) Dividend In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the proceedings at the 70th Annual General Meeting of the Company held through Video Conferencing or Other Audio-Visual Means on Friday, August 12, 2022, which commenced at 4.00 p.m. (IST) and concluded at 6.05 p.m. (IST). Kindly take the above information on record. Submission of voting results of Ballot process and Remote E-voting under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinisers report (As per BSE Announcement Dated on 12/08/2022) Fermenta Biotech Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 13/08/2022)

AGM Date: 29 Sep 2023

We write to inform you that the Board of Directors of the Company at its meeting held on August 11, 2023 has, inter alia, approved / recommended the following: (1) Unaudited Financial Results for the quarter ended June 30, 2023 along with Limited Review Reports (2) Annual General Meeting (AGM) Date: (3) Dividend and Record Date: (4) Dividend Payment Date: (5) Details of KMPs authorised to determine materiality of an event or information Annual Report of the Company for the financial year 2022-23 (along with the Notice of 71st AGM of the Company which is scheduled to be held on Friday, September 29, 2023 at 3:00 p.m. (IST) (As Per BSE Announcement dated on 06.09.2023) Declaration of voting results along with Scrutiniser''s report for 71st AGM held on 29th September 2023 (As Per BSE Announcement Dated on 29.09.2023)

AGM Date: 12 Aug 2024

The AGM of the members of the Company will be held on Monday, August 12, 2024 through Video Conferencing or Other Audio-Visual Means, in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The Notice of AGM, Board's Report and the Annual Report for the Financial Year 2023-24 shall be sent to the members within the statutory time limits. Annual Report 2023-24 (As Per BSE Announcement dated on 20.07.2024)

EGM Date: 02 Sep 2022

COM 02/09/2022 In connection with the meeting of the Equity Shareholders of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking approval for the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company' or 'Company') and their respective Shareholders ('Scheme'), we would like to inform that the Equity Shareholders of the Company have approved the Scheme with the requisite majority. The consolidated report of scrutinizer along with the scrutinizer's report in respect of public shareholding issued by Mr. V. N. Deodhar, Practicing Company Secretaries, is enclosed herewith. In connection with the meeting of the Secured Creditors of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking approval for the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company' or 'Company') and their respective Shareholders ('Scheme'), we would like to inform that the Secured Creditors of the Company have approved the Scheme with the requisite majority. The report of scrutinizer issued by Ms. Suman Sureka, Practicing Company Secretaries is enclosed herewith. Submission of voting results of Voting at the Meeting and Remote E-Voting and under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Approval for the composite scheme of amalgamation and arrangement amongst DVK Investments Private Limited ('Transferor company1') and Aegean Properties limited ('Transferor company 2') and Fermenta Biotech Limited ('Transferee Company') and their respective shareholders under the provision of sections 230 to 232 of the companies Act, 2013. In connection with the meeting of the Unsecured Creditors of Fermenta Biotech Limited held on September 02, 2022 convened pursuant to the order of the NCLT dated July 19, 2022 for seeking approval for the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited ('FBL' or 'Transferee Company' or 'Company') and their respective Shareholders ('Scheme'), we would like to inform that the Unsecured Creditors of the Company have approved the Scheme with the requisite majority. The report of scrutinizer issued by Ms. Suman Sureka, Practicing Company Secretaries is enclosed herewith. Fermenta Biotech Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 02.09.2022)